Press Releases 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Eagle Pharmaceuticals Successfully Completes Clinical Treatment Portion of Its Safety and Efficacy Study of Ryanodex for Exertional Heat Stroke 10/6/15 Eagle Pharmaceuticals Receives New Patent for Bendamustine Rapid Infusion Product 9/25/15 Eagle Pharmaceuticals, Inc. Reports Second Quarter 2015 Results 8/11/15 Eagle Pharmaceuticals to Discuss Second Quarter 2015 Financial Results on August 11, 2015 7/31/15 Eagle Pharmaceuticals’ RTU Bivalirudin NDA Accepted for Filing 7/23/15 Eagle Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference 6/30/15 Eagle Pharmaceuticals to Present at Two Investor Conferences in June 5/21/15 Eagle Pharmaceuticals Submits NDA for Ready-to-Use Bivalirudin to FDA 5/20/15 New Patent Issued for Eagle Pharmaceuticals’ Bendamustine Rapid Infusion Product 5/19/15 Eagle Pharmaceuticals, Inc. Reports First Quarter 2015 Results 5/12/15 Pagination First page Previous page Page 1 Current page 2 Page 3 Page 4 Next page Last page
